Literature DB >> 20965618

Multivariate SAR/QSAR of 3-aryl-4-hydroxyquinolin-2(1H)-one derivatives as type I fatty acid synthase (FAS) inhibitors.

Eduardo Borges de Melo1.   

Abstract

Two multivariate studies, a PCA-SAR and a PLS-QSAR, of 3-aryl-4-hydroxyquinolin-2(1H)-one derivatives described as type I fatty acid synthase (FAS) inhibitors, are presented in this work. The variable selection was performed with the Fisher's weight and Ordered Predictors Selection (OPS) algorithm, respectively. In the PCA, a separation between active and inactive compounds was obtained by six descriptors (topological and geometrical). The PLS model presented five descriptors and two Latent Variables. Leave-N-out cross validation and y-randomization test showed that the model presented robustness and no chance correlation, respectively, and the descriptors indicated that the FAS inhibition depends on electronic distribution of the investigated compounds. The model obtained in this study may provide a guidance for proposition of new FAS inhibitors.
Copyright © 2010 Elsevier Masson SAS. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20965618     DOI: 10.1016/j.ejmech.2010.09.044

Source DB:  PubMed          Journal:  Eur J Med Chem        ISSN: 0223-5234            Impact factor:   6.514


  3 in total

1.  In silico investigation of agonist activity of a structurally diverse set of drugs to hPXR using HM-BSM and HM-PNN.

Authors:  Yi-Ming Zhang; Mei-Jia Chang; Xu-Shu Yang; Xiao Han
Journal:  J Huazhong Univ Sci Technolog Med Sci       Date:  2016-07-05

Review 2.  Reviewing ligand-based rational drug design: the search for an ATP synthase inhibitor.

Authors:  Chia-Hsien Lee; Hsuan-Cheng Huang; Hsueh-Fen Juan
Journal:  Int J Mol Sci       Date:  2011-08-17       Impact factor: 5.923

3.  A QSAR Study of Matrix Metalloproteinases Type 2 (MMP-2) Inhibitors with Cinnamoyl Pyrrolidine Derivatives.

Authors:  Eduardo Borges de Melo
Journal:  Sci Pharm       Date:  2012-01-31
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.